Discontinuation report ENBREL
| Report ID | 168157 |
| Drug Identification Number | 02242903 |
| Brand name | ENBREL |
| Common or Proper name | etanercept for injection |
| Company Name | IMMUNEX CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | WATER ETANERCEPT |
| Strength(s) | 1ML 25MG |
| Dosage form(s) | POWDER FOR SOLUTION LIQUID KIT |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 25 mg/vial |
| ATC code | L04AB |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-12-15 |
| Actual discontinuation date | 2022-12-14 |
| Remaining supply date | 2022-12-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ONE AMGEN CENTRE DRIVE THOUSAND OAKS, CALIFORNIA UNITED STATES 91320-1799 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-01-13 | French | Compare |
| v5 | 2023-01-13 | English | Compare |
| v4 | 2022-10-18 | French | Compare |
| v3 | 2022-10-18 | English | Compare |
| v2 | 2022-08-29 | French | Compare |
| v1 | 2022-08-29 | English | Compare |
Showing 1 to 6 of 6